Chinese pharmaceutical M&A deal value from financial buyers 2016-2019, by type
Investment in the health and pharmaceutical industry has seen a robust growth in China in the recent few years. In 2019, there were 187 publicly disclosed merger and acquisition deals conducted by financial buyers in the Chinese pharmaceutical sector. A majority was made by private equity funds - about 8.7 billion U.S. dollars.